C07D 215/08
With acylated ring nitrogen atom
Official title: with acylated ring nitrogen atom
C07D215/08 (With acylated ring nitrogen atom) appears on 142 US grants and 138 published applications in this corpus.
Search patents in C07D- Granted patents
- 142
- Published applications
- 138
- Assignees
- 119
- Inventors
- 617
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 5 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 4 | 4 |
| 2004 | 1 | 5 |
| 2005 | 1 | 6 |
| 2006 | 1 | 3 |
| 2007 | 2 | 8 |
| 2008 | 3 | 11 |
| 2009 | 4 | 8 |
| 2010 | 2 | 8 |
| 2011 | 6 | 4 |
| 2012 | 6 | 10 |
| 2013 | 6 | 6 |
| 2014 | 10 | 8 |
| 2015 | 4 | 8 |
| 2016 | 2 | 2 |
| 2017 | 7 | 6 |
| 2018 | 5 | 9 |
| 2019 | 7 | 3 |
| 2020 | 3 | 4 |
| 2021 | 3 | 5 |
| 2022 | 2 | 4 |
| 2023 | 2 | 4 |
| 2024 | 1 | 6 |
| 2025 | 2 | 2 |
| 2026 | 4 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst and an additive14 Jul 2026US 12,679,808 B2Bayer Aktiengesellschaft
- Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst2 Jun 2026US 12,643,860 B2Bayer Aktiengesellschaft
- Inhibitors of MLH1 and/or PMS2 for cancer treatment17 Feb 2026US 12,552,758 B2NeoPhore Limited
- Process comprising the use of new iridium catalysts for enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines9 Sep 2025US 12,410,138 B2Bayer Aktiengesellschaft
- Agent for restoring metal homeostasis25 Jun 2026US 2026/0174721 A1Oxford Antibiotic Group GmbH
- Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst15 Jan 2026US 2026/0015326 A1Bayer Aktiengesellschaft
- P300/cbp hat inhibitors17 Jul 2025US 2025/0230137 A1Constellation Pharmaceuticals, Inc.
- Novel b0at1 inhibitor29 May 2025US 2025/0170126 A1Mitsubishi Tanabe Pharma Corporation
- Novel compound for capping layer and organic light emitting device including same22 Aug 2024US 2024/0279158 A1Dongjin Semichem Co., Ltd.
Most cited
By later US patents
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Inhibitors of factor Xa89US 6,534,535 B1Millennium Pharmaceuticals, Inc. · 2003
- Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines67US 5,312,820 AMerck & Co., Inc. · 1994
- Condensed heterocyclic ketone derivatives and their use51US 5,462,934 ATakeda Chemical Industries, Ltd. · 1995
- Aza-bicycles which modulate the inhibition of cell adhesion50US 6,608,084 B1Aventis Pharma S.A. · 2003